Cargando…
Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis
BACKGROUND: Cladribine is a synthetic purine analogue that interferes with DNA synthesis and repair next to disrupting cellular proliferation in actively dividing lymphocytes. The compound is approved for the treatment of multiple sclerosis (MS). Cladribine can cross the blood–brain barrier, suggest...
Autores principales: | Schroeter, Christina B., Rolfes, Leoni, Gothan, K. S. Sophie, Gruchot, Joel, Herrmann, Alexander M., Bock, Stefanie, Fazio, Luca, Henes, Antonia, Narayanan, Venu, Pfeuffer, Steffen, Nelke, Christopher, Räuber, Saskia, Huntemann, Niklas, Duarte-Silva, Eduardo, Dobelmann, Vera, Hundehege, Petra, Wiendl, Heinz, Raba, Katharina, Küry, Patrick, Kremer, David, Ruck, Tobias, Müntefering, Thomas, Budde, Thomas, Cerina, Manuela, Meuth, Sven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641831/ https://www.ncbi.nlm.nih.gov/pubmed/36348455 http://dx.doi.org/10.1186/s12974-022-02588-7 |
Ejemplares similares
-
Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced Colitis
por: Pfeuffer, Steffen, et al.
Publicado: (2022) -
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment
por: Rolfes, Leoni, et al.
Publicado: (2021) -
Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres
por: Pfeuffer, Steffen, et al.
Publicado: (2021) -
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Rolfes, Leoni, et al.
Publicado: (2020) -
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Huntemann, Niklas, et al.
Publicado: (2021)